NeoGenomics, Inc. Litigation Settlement Gain
NeoGenomics, Inc. (NEO) reported Litigation Settlement Gain of $1.20 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-28.
Financial Statements › Income Statement › Other Income
us-gaap:LitigationSettlementGain · last filed 2026-07-28
- NeoGenomics, Inc. litigation settlement gain for the quarter ending 2026-06-30 was $1.20M.
| Period end | Litigation Settlement Gain 3 month | Litigation Settlement Gain 6 month |
|---|---|---|
| 2026-06-30 | $1.20M 10-Q · filed 2026-07-28 | $1.20M 10-Q · filed 2026-07-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |